This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Iovance Biotherapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zelanna Goldberg: Innovator in Tumor Infiltrating Lymphocyte Therapies
Introduction
Zelanna Goldberg is a prominent inventor based in Redwood City, CA. He has made significant contributions to the field of cancer treatment, particularly through his innovative approaches to immunotherapy. His work focuses on enhancing the effectiveness of tumor infiltrating lymphocyte therapies.
Latest Patents
Zelanna holds a patent for "Treatment with Tumor Infiltrating Lymphocyte Therapies in Combination with CTLA-4 and PD-1 Inhibitors." This patent represents a crucial advancement in the treatment of cancer, aiming to improve patient outcomes through a combination of therapies.
Career Highlights
Zelanna Goldberg is associated with Iovance Biotherapeutics, Inc., where he applies his expertise in developing cutting-edge cancer therapies. His work has been instrumental in pushing the boundaries of current treatment methodologies.
Collaborations
Zelanna collaborates with notable professionals in the field, including Maria Fardis and Friedrich-Reinhard Graf Finck Von Finckenstein. These partnerships enhance the research and development of innovative cancer treatments.
Conclusion
Zelanna Goldberg's contributions to cancer therapy through his patent and work at Iovance Biotherapeutics, Inc. highlight his role as a key innovator in the medical field. His efforts continue to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile